World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   552 records for 244 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusMain ID Public TitleDate of Registration
Not recruitingNCT02273765
Raltegravir Versus Efavirenz in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis
20/10/2014
Not recruitingNCT02250768
Effects of Embryogen in RIF Patients
23/09/2014
Not recruitingNCT02244866
Efficacy of Pergoveris in Aged IVF Patients
16/09/2014
RecruitingNCT02262403
Hookworm Immune Regulation Project
16/09/2014
Not recruitingNCT02237365
A Pilot Study of Adjunctive Aspirin for the Treatment of HIV Negative Adults With Tuberculous Meningitis
09/09/2014
Not recruitingNCT02208986
GnRHa Trigger in Asian Oocyte Donors- a Dose Finding Study
29/07/2014
AuthorisedEUCTR2014-001473-14-SE
OS Study of pembrolizumab (MK-3475) vs. SOC in Treatment Naïve Subjects with PD-L1 Positive Advanced or Metastatic NSCLC (Keynote 042) 24/07/2014
AuthorisedEUCTR2013-004435-72-CZ
An open-label extension and safety monitoring study for patients with ulcerative colitis previously enrolled in etrolizumab phase III studies
Recruitment statusMain IDPublic titleDate of registration
AuthorisedEUCTR2013-004435-72-LVAn open-label extension and safety monitoring study for patients with ulcerative colitis previously enrolled in etrolizumab phase III studies22/07/2014
AuthorisedEUCTR2013-004435-72-ATAn open-label extension and safety monitoring study for patients with ulcerative colitis previously enrolled in etrolizumab phase III studies22/07/2014
AuthorisedEUCTR2013-004435-72-HRAn open-label extension and safety monitoring study for patients with ulcerative colitis previously enrolled in etrolizumab phase III studies05/09/2014
AuthorisedEUCTR2013-004435-72-LTAn open-label extension and safety monitoring study for patients with ulcerative colitis previously enrolled in etrolizumab phase III studies22/07/2014
AuthorisedEUCTR2013-004435-72-NOAn open-label extension and safety monitoring study for patients with ulcerative colitis previously enrolled in etrolizumab phase III studies06/08/2014
AuthorisedEUCTR2013-004435-72-EEAn open-label extension and safety monitoring study for patients with ulcerative colitis previously enrolled in etrolizumab phase III studies29/07/2014
AuthorisedEUCTR2013-004435-72-HUAn open-label extension and safety monitoring study for patients with ulcerative colitis previously enrolled in etrolizumab phase III studies30/10/2014
AuthorisedEUCTR2013-004435-72-GRAn open-label extension and safety monitoring study for patients with ulcerative colitis previously enrolled in etrolizumab phase III studies20/08/2014
21/07/2014
AuthorisedEUCTR2013-004473-28-SE
A 52-week, double-blind, randomised, multi-centre, phase III, parallel-group study in patients 12 years and older with asthma, evaluating the efficacy and safety of Symbicort (budesonide/formoterol) Turbuhaler 160/4.5 µg ‘as needed’ compared with Pulmicort (budesonide) Turbuhaler 200 µg twice daily plus terbutaline Turbuhaler 0.4 mg ‘as needed’ 16/07/2014
RecruitingNCT02175849
Intensifying Multi-Drug Resistant Tuberculosis Contact Tracing by Social Network Analysis
25/06/2014
    
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.2 - Version history